Clinical trial
Hypnosis Versus Intravenous Sedation With Concentration Objective (SIVOC) by Remifentanil During TAVI Procedures: Impact on Perioperative Confusion
NCT03974269 is registered in ClinicalTrials.gov with Centre Chirurgical Marie Lannelongue as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypnosis Versus Intravenous Sedation With Concentration Objective (SIVOC) by Remifentanil During TAVI Procedures: Impact on Perioperative Confusion
- Lead sponsor
- Centre Chirurgical Marie Lannelongue
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 11, 2018
- Completion date
- June 11, 2021
- Enrollment
- 186 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.